Savient Pharma (SVNT) Posts Q4 GAAP Loss of 1c; Launches KRYSTEXXA in U.S.

Go back to Savient Pharma (SVNT) Posts Q4 GAAP Loss of 1c; Launches KRYSTEXXA in U.S.